Vet Pathol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larcher, T.
Right arrow Articles by Cherel, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larcher, T.
Right arrow Articles by Cherel, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Vet Pathol 45:154-158 (2008)
© 2008 American College of Veterinary Pathologists


BRIEF COMMUNICATIONS AND CASE REPORTS

Polysaccharide Storage Myopathy in Cob Normand Draft Horses

T. Larcher, B. Herszberg, S. Molon-Noblot, L. Guigand, S. Chaffaux, G. Guerin and Y. Cherel

INRA, UMR703, Ecole Nationale Veterinaire, Nantes, F-44307 France (TL, LG, YC), INRA, Laboratoire de Genetique biochimique et de Cytogenetique, Jouy-en-Josas, F-78350 France (BH, SC, GG), and MSD-Chibret, Centre de recherche Mirabel, Riom, Clermont-Ferrand, F-63963 France (SMN)

Abstract

Gluteus medius muscle was sampled from 53 Cob Normand horses for histologic evaluation. Twenty horses (38%) exhibited amylase-resistant material in myocytes consistent with polysaccharide storage myopathy. Diameter of affected type II fibers was increased (67.7 ± 21.4 µm) compared with normal ones (57.3 ± 19.7 µm). Two groups were distinguished by quantitative study. The first group (n = 14; 26%) was characterized by a low percentage of fibers (m = 0.98%) containing aggregates occurring singly or in perifascicular clusters without myopathic changes. The second group (n = 6; 11%) was characterized by a high percentage (m = 18.1%) of fibers containing aggregates scattered in biopsy with chronic myopathic changes. Rebiopsy of 4 horses showed an increase with time in the number of aggregate-containing fibers for horses of the first group only. In 1 necropsied horse, aggregates were observed in a wide range of muscles including smooth muscles. Ultrastructurally, granular material was found interspersed among arrays of filamentous material.


Key words: Histopathology; horses; myopathy; polysaccharide storage.

Equine polysaccharide storage myopathy (EPSSM) is a metabolic myopathy of unclear origin that results in excessive accumulation of polysaccharides in the skeletal muscle fibers. This muscle disorder has been reported in many horse and pony breeds,4,10 with the highest incidence recorded in draft horses.5 Percheron, Belgian, Clydesdale, and Shire draft horse–related breeds have been previously reported affected.6 Cob Normand breed is an average-sized horse named after the English Cob and developed as a distinct breed at the beginning of the 20th century from crossings of native horses with Thoroughbred. In 1995, there were 803 brood mares in activity. The sudden death of 2 full-sister mares with histologic features resembling EPSSM elicited a broader study on incidence, histologic, morphometric, and ultrastructural characteristics of the disorder in this breed.

Biopsies from the gluteus medius muscle were obtained from 53 Cob Normand horses aged 1 to 22 years (mean ± S.D. age, 9 ± 5 years). Additional biopsies were performed for a second time on 4 of these horses, 6 months (n = 2) to 2 years (n = 2) after the initial biopsy with EPSSM diagnosis. One affected horse (8 years) was subsequently euthanatized. Sixty-eight different striated muscles (cardiac and 3 respiratory muscles and respectively 19, 21, 8, 13, and 3 muscles of the anterior and posterior limbs, the trunk, the neck, and the head) and 55 tissues were sampled during a complete necropsy examination. All muscle samples were frozen in isopentane cooled with liquid nitrogen. Other tissue samples were fixed in formaldehyde 4% (Panreac Quimica, Barcelona, Spain). Nonmuscular tissue samples were embedded in paraffin and cut into 6-µm-thick sections. Frozen muscle samples were serially sectioned (8 µm thick). Sections were treated with a battery of tinctorial staining techniques (hematoxylin–eosin–safranine [HES]), histochemical procedures (periodic acid–Schiff [PAS] with or without incubation for 20 minutes at 37°C with {alpha}-amylase) and histoenzymologic procedures (nicotinamide adenine dinucleotide dehydrogenase-tetrazolium reductase [NADH-TR] for oxidative activity, myofibrillar ATPase, pH = 4.2; 4.63 and 10.4 for fiber typing). Additional staining tests were performed on sections of skeletal and cardiac muscles, deep inguinal lymph node, skin, and bladder: Best carmine and methenamine silver for polysaccharide identification, Lugol's iodine and IKI-glycerol for length characterization of polysaccharidic chains,3 Alcian blue, toluidine blue, and Hale with or without hyaluronidase digestion for acidic residues identification, Congo Red for specific conformation identification, and Oil Red O for lipid identification. Acid phosphatase activity was also revealed for lysosomal membrane identification, and PAS staining was performed after incubation for 20 minutes, 1 hour, 4 hours, and overnight at 37°C with {alpha}-amylase, diastase, or human saliva. Morphometric analysis was performed using a digital camera (Nikon DXM 1200, Badhoevedo, Netherlands) combined with image-analyzing software (Lucia imaging software, Laboratory Imaging Inc., Prague, Czech Republic). Percentages of aggregate-containing and vacuolated fibers were calculated. As many microscopic fields as necessary were randomly selected in PAS-amylase–stained sections to observe at least 300 muscle fibers (436 ± 116 fibers per sample). The numbers of total and aggregate-containing fibers were then determined (variation coefficient of 3.4%). In the same way, at least 100 muscle fibers (158 ± 50 fibers) in HES-stained sections were observed to determine the percentage of vacuolated fibers and minimal Ferret (variation coefficients of 10% and 0.75%, respectively). Comparisons were made using analysis of variance. Additional biopsies from 5 affected horses aged 3 to 19 years were designated for routine electron microscopy and subsequently fixed in 2.5% buffered glutaraldehyde, postfixed in osmium tetroxide, embedded in epoxy resin, cut into 1-µm-thick sections, stained with uranyl acetate and lead citrate, and then examined by transmission electron microscopy.

Intracytoplasmic presence of amylase-resistant material, used as diagnosis criteria for EPSSM, was observed in biopsies of 20 out of 53 horses, either subsarcolemal or centrally located, displacing the myofibrils (Fig. 1). Aggregates of this material appeared gray with HES, purple with PAS and Best carmine, brown with Lugol's iodine and IKI-glycerol, blue with Alcian blue, and light blue with Hale following or not incubation with hyaluronidase. These were unstainable with methenamine silver, toluidine blue, Red Congo, Oil Red O, and acid phosphatase. PAS and Best carmine stains were resistant to {alpha}-amylase and diastase short digestion but sensitive to long digestion in diastase (4 hours and more). Type II fibers, showing a positive ATPase histoenzymatic reaction (pH = 10.4), were preferentially affected, although type I fibers could also be affected in severe cases. With PAS, aggregate-containing fibers showed a pale cytoplasm in comparison with adjacent aggregate-free fibers displaying purple to dark blue cytoplasm. This suggests an extensive intracytoplasmic accumulation of glycogen. Biopsies of 24 horses exhibited numerous subsarcolemmal vacuoles with granular basophilic material with HES. Ten plus or minus eight percent of the muscular fibers and up to 10% of the affected fiber area was involved. PAS staining was irregular and, where present, was {alpha}-amylase sensitive; other staining procedures were negative. No oxidative or ATPase activities were observed. In the majority of cases (n = 18 out of 24), both vacuoles and amylase-resistant material were present, but the numbers of vacuoles were not correlated with the numbers of material aggregates. In the other 6 cases, subsarcolemmal vacuoles were the sole myocytic lesion, and the corresponding horses were considered negative for EPSSM. Vacuoles were either rarely observed (less than 1% of fibers, n = 5) or numerous (7.3% of fibers, n = 1). The last case corresponded to the biopsy of a 1-year-old horse, the myocytic vacuoles being associated with mild interstitial infiltration by macrophages and lymphocytes. Ultrastructural features in the 5 horses examined included large masses of nonmembrane-bound granular material with heterogeneous electron density that were unevenly distributed throughout the cytoplasm of the fibers. In some cases, filamentous material (2 to 4 µm wide, up to 15 µm long) was admixed. Myofibers also showed mild myofibrillar and mitochondrial loss.


Figure 01
View larger version (87K):
[in this window]
[in a new window]

 
Fig. 1. Serial transverse sections of gluteal muscle; Cob Normand horse with polysaccharide storage myopathy (EPSSM). Numerous fibers contained large aggregates, either peripheral or intermyofibrillar, stained with PAS and showing {alpha}-amylase resistance. HES (1A), PAS (1B), PAS following {alpha}-amylase digestion (1C). Bar = 20 µm.

 
Diameters of muscle fibers were measured using minimal Ferret. Type I fibers were too rarely observed to yield statistically relevant results. Diameters of type IIA and type IIB fibers were measured according to the absence of myocytic lesion, the presence of vacuoles, or the presence of aggregates (respectively 60.6 ± 21.3; 77.3 ± 18.4; 69.0 ± 22.3 µm for type IIA fibers; 53.1 ± 16.9; 72.1 ± 17.4; 66.0 ± 20.4 µm for type IIB fibers). Standard deviations were not significantly different between control fibers and vacuolated fibers, on the one hand, and between control fibers and aggregate-containing fibers, on the other hand. The minimal Ferret mean value for fibers containing vacuoles or aggregates was higher compared with the mean value for adjacent normal fibers (P < 0.05). Other myopathic changes included internal nuclei, segmental necrosis, mononuclear infiltration, and interstitial fat infiltration.

Quantitative evaluation of the myocytic changes was performed on the biopsies of affected horses (Fig. 2). The percentages of affected muscle fibers were distributed bimodally, and 2 groups of biopsies can be distinguished: 1) 1 group composed of biopsies of 14 horses showing less than 3% (0.98 ± 0.92%) of type II fibers with aggregates occurring in the center of a single or small clusters of perifascicular fibers and 2) a second group of biopsies of 6 horses showing 9 to 30% (18.1 ± 5.7%) of fibers of both types, with aggregates evenly scattered through the sample. Segmental necrosis was also associated. There were no significant differences (P > 0.05) between the 2 groups concerning the number of subsarcolemmal vacuoles or the ages of the animals. Repeated histologic examinations were performed on 4 horses, including 2 from each group. After 6 months, animals could still be attributed to the same group. However, in the 2 biopsies of the first group, there was a marked increase in the number of aggregate-containing fibers between the first and the second biopsy (from less than 0.3% to 0.4% for 1 horse; from 0.5 to 1.3% for the second). No significant increase was observed in the 2 biopsies of the second group. The number of vacuolated fibers increased with time in all cases (respectively from 15.0; 17.6; 7.3; and 9.1% in the initial biopsy to 17.7; 71.0; 18.3; and 34.1% in the second biopsy).


Figure 02
View larger version (13K):
[in this window]
[in a new window]

 
Fig. 2. Mean percentages of aggregate-containing fibers from 2 muscle biopsy groups with distinct histological presentation of EPSSM. a and b were significantly different. n = number of horses.

 
The necropsied horse belonged to the second group (18.9% of affected fibers). PAS-positive and amylase-resistant aggregates were observed in all sampled striated muscles, except in lingual muscle and in the masseter, splenius, longissimus capitis, extensor carpi ulnaris, and flexor digitorum superficialis. Nevertheless, abundant vacuoles were found in the extensor carpi ulnaris and flexor digitorum superficialis muscles. Extensive fibrosis foci and intracytoplasmic PAS-positive amylase-resistant aggregates were observed in myocardial muscle sections (Fig. 3). Similar amylase-resistant material was also observed in several smooth muscles: arrector muscle of skin, cavernous muscle of penis as well as the muscular layer of the bladder and ureter. All other observed smooth muscles were normal. In superficial inguinal lymph nodes, macrophages with intracytoplasmic vacuoles of various sizes (5 to 15 µm) containing PAS-positive amylase-resistant material were also present. In cardiac and smooth muscle fibers and in nodal macrophages, these aggregates showed similar histochemical properties to those described for aggregates in skeletal muscles.


Figure 03
View larger version (86K):
[in this window]
[in a new window]

 
Fig. 3. Serial sections of heart; Cob Normand horse with EPSSM. Some cardiac muscle fibers contained aggregates stained with PAS and showing {alpha}-amylase resistance. HES (3A), PAS (3B), PAS following {alpha}-amylase digestion (3C). Bar = 20 µm.

 

Figure 04
View larger version (179K):
[in this window]
[in a new window]

 
Fig. 4. Bladder; Cob Normand horse with EPSSM. PAS-positive and amylase-resistant aggregates were observed in cavernous muscle fibers. PAS following {alpha}-amylase digestion. Bar = 20 µm.

 
This report is the first description of the disease in the Cob Normand breed. In this breed, EPSSM has many features in common with the disease as described previously in other breeds, i.e., preferential involvement of type II fibers, material staining characteristics consistent with abnormal polysaccharide, and diffuse accumulation of excessive intramuscular glycogen.4,6 In this study, diameter of fibers with aggregates is shown to be larger compared with unaffected fibers of the same fiber type. This could be caused by compensatory hypertrophy or by the accumulation of abnormal material.

Definitive diagnosis of EPSSM relies on the pathologic evaluation of a muscle biopsy sample, although the criteria for histologic diagnosis are somewhat controversial. This report restrict diagnosis to the finding of PAS-positive and amylase-resistant material within muscle fibers,4 but others extend diagnosis to include horses with only PAS-positive and amylase-sensitive vacuoles.5,9 As others draft horses, Cob Normand horses are prone to develop higher numbers of aggregates than others breeds.9 The abundance of aggregates also increases with age,2,6 with the youngest affected animals of our study (3 years old, n = 3) typically exhibiting very few aggregates. Subsarcolemmal vacuoles are sometimes reported to be the first detectable finding in young affected horses, prior to the development of amylase-resistant aggregates.2 In our study, this feature was observed in a 1-year-old horse for which a further biopsy to confirm diagnosis was refused by the owners.

PAS and Best carmine stains were consistent with the aggregates having a polysaccharide nature. Resistance to {alpha}-amylase digestion distinguishes this polysaccharide from glycogen. Moreover, the brown staining with iodine and the sensitivity to long diastase digestion distinguish the polysaccharide from amylopectin.3 This partial resistance to glycogenolytic enzymes and the uneven electron density of the granular material may be related to an abnormal structure of the polysaccharide molecule. The blue Hale staining and the presence of large arrays of ultrastructural filamentous material can be attributed to the partial incorporation of another kind of molecule such as an acidic mucopolysaccharide, which could also explain the glycogenolytic resistance. Taken together, these features strongly suggest a polysaccharide mixture. Ubiquitine expression has been recently detected in muscle fibers of horses with EPSSM. This could reflect abnormal folding or other alteration of the protein component of the glycogen molecule.8

Previous studies on muscular aggregates distribution focused on a few skeletal muscles including limb and epaxial muscles.4,6,7,9 Extensive numbers of striated muscles were evaluated here for the first time in 1 horse. The majority of striated muscles showed severe lesions, including myocardial and diaphragmatic muscles, as already reported in other draft horses.9 Aggregates were also found in mononuclear cells of the deep inguinal lymph node. Polysaccharides from necrotic affected fibers can be phagocyted by muscular interstitial macrophages,6 which could explain the presence of these polysaccharides in macrophages in lymph nodes draining severely affected muscles. Presence of aggregates in smooth muscle is reported here for the first time in a polysaccharide storage disease. In this aging animal, polyglucosan Lafora-type bodies and lipofuscin were ruled out, as the former appears black with methenamine silver and blue with Lugol's iodine1 and the latter appears red with Oil Red O and has acid phosphatase activity. Further study of these rarely affected tissues is clearly needed to identify reasons and mechanisms involved in broad amylase-resistant material deposition.

Acknowledgement

This project was supported by the Haras Nationaux.

References

  1. Cavanagh JB. Corpora-amylacea and the family of polyglucosan diseases. Brain Res Brain Res Rev 29:265–295, 1999[CrossRef][Medline]
  2. De La Corte FD, Valberg SJ, MacLeay JM, Mickelson JR. Developmental onset of polysaccharide storage myopathy in 4 Quarter Horse foals. J Vet Intern Med 16:581–587, 2002[CrossRef][Web of Science][Medline]
  3. Render JA, Common RS, Kennedy FA, Jones MZ, Fyfe JC. Amylopectinosis in fetal and neonatal Quarter Horses. Vet Pathol 36:157–160, 1999[Abstract]
  4. Valberg SJ, Cardinet GH, Carlson GP, DiMauro S. Polysaccharide storage myopathy associated with recurrent exertional rhabdomyolysis in horses. Neuromuscul Disord 2:351–359, 1992[CrossRef][Medline]
  5. Valentine BA, Cooper BJ. Incidence of polysaccharide storage myopathy: necropsy study of 225 horses. Vet Pathol 42:823–827, 2005[Abstract/Free Full Text]
  6. Valentine BA, Credille KM, Lavoie JP, Fatone S, Guard C, Cummings JF, Cooper BJ. Severe polysaccharide storage myopathy in Belgian and Percheron draught horses. Equine Vet J 29:220–225, 1997[Web of Science][Medline]
  7. Valentine BA, de Lahunta A, Divers TJ, Ducharme NG, Orcutt RS. Clinical and pathologic findings in two draft horses with progressive muscle atrophy, neuromuscular weakness, and abnormal gait characteristic of shivers syndrome. J Am Vet Med Assoc 215:1621, 1661–1665, 1999
  8. Valentine BA, Flint TH, Fischer KA. Ubiquitin expression in muscle from horses with polysaccharide storage myopathy. Vet Pathol 43:270–275, 2006[Abstract/Free Full Text]
  9. Valentine BA, Habecker PL, Patterson JS, Njaa BL, Shapiro J, Holshuh HJ, Bildfell RJ, Bird KE. Incidence of polysaccharide storage myopathy in draft horse-related breeds: a necropsy study of 37 horses and a mule. J Vet Diagn Invest 13:63–68, 2001[Abstract/Free Full Text]
  10. Valentine BA, McDonough SP, Chang YF, Vonderchek AJ. Polysaccharide storage myopathy in Morgan, Arabian, and Standardbred related horses and Welsh-cross ponies. Vet Pathol 37:193–196, 2000[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larcher, T.
Right arrow Articles by Cherel, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larcher, T.
Right arrow Articles by Cherel, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS